Semaglutide to Reduce Atrial Fibrillation Burden

Clinical trial NCT05209165 · SUSPENDED

Trial details

NCT number: NCT05209165
Sponsor: San Francisco Veterans Affairs Medical Center
Status: SUSPENDED
Phase: Phase 4
Study type: INTERVENTIONAL

Atrial Fibrillation Obesity Overweight

Start date: 2023-05-01
Primary completion: 2027-05-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.